# Exploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort Study

> **NCT06861114** · — · RECRUITING · sponsor: **Zhujiang Hospital** · enrollment: 38 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

- **DIAGNOSTIC_TEST:** Urine proteomics

## Key facts

- **NCT ID:** NCT06861114
- **Lead sponsor:** Zhujiang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-20
- **Primary completion:** 2027-12-20
- **Final completion:** 2027-12-31
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06861114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06861114, "Exploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06861114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*